Effects of changes in basal/total daily insulin ratio in type 2 diabetes patients on intensive insulin therapy including insulin glargine (JUN-LAN Study 6)

2008 ◽  
Vol 81 (2) ◽  
pp. e1-e3 ◽  
Author(s):  
Motoyuki Tamaki ◽  
Tomoaki Shimizu ◽  
Akio Kanazawa ◽  
Yoshio Fujitani ◽  
Hirotaka Watada ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Insulin Therapy ◽  
Intensive Insulin Therapy ◽  
Daily Insulin ◽  
Diabetes Patients

scholarly journals The Effect Of Diet Composition On Weight Gain in Obese, Type 2 Diabetes Patients Receiving Intensive Insulin Therapy

2015 ◽  
Vol 6 (2) ◽  
pp. 111-116
Author(s):  
Roland Villareal
Keyword(s):  
Type 2 Diabetes ◽  
Weight Gain ◽  
Insulin Therapy ◽  
Intensive Insulin Therapy ◽  
Diet Composition ◽  
High Carbohydrate ◽  
Total Calorie ◽  
Mufa Diet ◽  
Diabetes Patients

This study was conducted to contribute to the limiting existing body of literature about diet and prevention of weight gain when administering intensive insulin therapy.  The effects of a high- monounsaturated fatty acid (MUFA) diet compared with a conventional diabetic diet have not been studied in insulin treated patients.  A growing body of evidence assessed that diets rich in high-MUFA foods had similar glycemic results, as do low-fat, high carbohydrate diets.  However, a high-MUFA diet did not raise triglycerides as suspected.  Ros (2003) stated that high-MUFA energy controlled diets do not promote weight gain and are more acceptable for weight loss and/or maintenance. A MUFA diet can be used as an alternate to the conventional American Diabetic Association (ADA) diet when managing obese type 2 diabetes patients treated with intensive insulin therapy.  Dietary restriction to 1600 calories in diabetes patients on intensive insulin therapy decreased the A1C value by 1.3 points in the ADA group and 1.5 points in the MUFA group without weight gain and without additional insulin required.  In conclusion the total calorie count was more important for preventing weight gain and reducing the A1C in patients on intensive insulin therapy than was dietary composition.

Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients

2007 ◽  
Vol 76 (1) ◽  
pp. 111-118 ◽  
Author(s):  
Chang-Yu Pan ◽  
Patrick Sinnassamy ◽  
Kab-Do Chung ◽  
Kwang-Won Kim
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Insulin Therapy ◽  
Nph Insulin ◽  
Diabetes Patients

Efficacy of Adding Once-Daily Insulin Glulisine in Japanese Type 2 Diabetes Patients Treated with Insulin Glargine and Sitagliptin

2014 ◽  
Vol 16 (10) ◽  
pp. 633-639 ◽  
Author(s):  
Mitsuyoshi Takahara ◽  
Toshihiko Shiraiwa ◽  
Naoto Katakami ◽  
Taka-aki Matsuoka ◽  
Iichiro Shimomura
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Glargine ◽  
Once Daily ◽  
Daily Insulin ◽  
Insulin Glulisine ◽  
Diabetes Patients
Sign in / Sign up

Export Citation Format

Share Document